Corona Virus Europe Health India medical

Johnson & Johnson granted approval by DCGI for use in Indian Soil

The US-based pharmaceutical company Johnson & Johnson had applied for Emergency Use Authorisation for its jab on Friday and was granted the approval the same day by the Drugs Controller General of India (DCGI) Johnson & Johnson’s single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya said on Read More…

Companies Corona Virus India medical Regulators

Latest Vaccine updates on covaxin covishield and Pfizer in India

Bharat Biotech, the manufacturer of Covaxin, has submitted its phase-3 clinical trial to the Central Drug Standards Control Organisation, claiming nearly 78% efficacy of its Covid-19 vaccine, which is currently being used for mass vaccination in India. An expert panel under the CDSCO on Tuesday reviewed the data, news agencies claimed quoting unnamed sources, but Read More…

Corona Virus Life Science medical

Vaccination helps to control third wave in India : Experts

Even though overall Covid-19 cases in India have declined over the past few days, the fears of a third wave of coronavirus have loomed in the country.   The Centre has directed the states and union territories to open up daily activities in a “carefully calibrated” manner.   On many occasions, medical experts have warned Read More…

Corona Virus Europe India Life Science medical

SARS-CoV-2 Delta variant Delta plus study is essential for future wave : Experts

In May, the WHO tagged B.1.617.2 strain as the ‘Delta’ variant of SARS-CoV-2. The variant was identified as one of the drivers of the second wave of coronavirus infections that devastated parts of the country earlier this year.   The ‘Delta’ variant has further mutated to form the ‘Delta plus’ or ‘AY.1’ variant.   Initial Read More…

Corona Virus Health India Life Science Life Style medical

Whom to give and whom not use of anti-Covid drug 2-DG , DRDO issue guidelines

The drug can be given to patients under the care and prescription of doctors as it issued directions for its use.  “Ideally, 2DG should be prescribed as early as possible by doctors for moderate to severe Covid patients for a maximum duration of up to 10 days,” DRDO said in a statement.  The first batch Read More…

India

SC not only bombarded Union govt on cost factors influence dual pricing but also details on 35000 Cr

A Bench of Justices DY Chandrachud, L Nageswara Rao and Ravindra Bhat, in its judgment in the suo motu case on COVID-19 issues, also noted that the policy does not prioritize persons with co-morbidities and other diseases and persons with disabilities.   “Due to the importance of vaccinating individuals in the 18-44 age group, the Read More…

India

Immunity period after Jab , Role of booster to stop New Variant Reduce Immunity : Experts Answered

Till date India  presently approved three Covid-19 vaccines for the use in the country ie.,  Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin and Russia’s Sputnik V, which are all two-dose vaccines.   As per the data ascertained by  Union  government of india  has recommended a gap of 12-16 weeks for Covishield, while it is Read More…

BJP Companies India Supreme Court

SC asked Union Govt policy document and refuse to touch vaccine differential price affidavit

In a suo-moto hearing on Covid-19, the Supreme Court on Monday whiplashed the Centre on differential pricing of vaccines. The Apex Court also demanded the Centre to produce their vaccine policy document.   Justice Chandrachud is heading the Bench that is presently hearing the suo motu matter on issues arising out of COVID-19 management across Read More…

America China Corona Virus Life Science medical United Kingdom

British Scientists claim “unique fingerprints” in Covid-19 manipulation in a laboratory

Two European scientists have claimed that the pandemic-causing SARS-CoV-2 was artificially created in a laboratory by Chinese scientists, who later covered their tracks by reverse engineering virus to give it an appearance of a natural pathogen.   Scientists also in their study stated “deliberate destruction, concealment or containment” of data at Chinese labs and notes Read More…

Asia Corona Virus Health India medical

WHO South East Asia Director says Vaccination is the only solution

Vaccination at the first available opportunity will be India’s way to prevent another wave says WHO South Asia Director    As the Covid-19 graph of India is plateauing, this is a time to be more cautious and get vaccinated at the first available opportunity, said.   The next surge a possible third wave of the Read More…